- Release Date: 21/07/21 09:21
- Summary: Grant Secured to Advance Pre-Clinical Studies Of ARG-007
- Price Sensitive: Yes
- Download Document 305.39KB
- Forums
- ASX - By Stock
- Ann: Grant Secured to Advance Pre-Clinical Studies Of ARG-007
AGN
argenica therapeutics limited
Add to My Watchlist
4.76%
!
33.0¢

Ann: Grant Secured to Advance Pre-Clinical Studies Of ARG-007
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $40.46M |
Open | High | Low | Value | Volume |
31.5¢ | 33.0¢ | 31.5¢ | $39.64K | 122.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 13773 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.320 |
2 | 30066 | 0.315 |
1 | 6509 | 0.310 |
2 | 53278 | 0.305 |
4 | 71166 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 13773 | 2 |
0.335 | 50000 | 1 |
0.340 | 6154 | 2 |
0.345 | 65555 | 1 |
0.350 | 35901 | 3 |
Last trade - 12.18pm 16/09/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online